Alexander C. Conley

Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease

Rosaria J. Rae, Jessica Marie Hunter Alberhasky, Marion Baillet, Debra A. Bangasser et autres

us, it, de, ca, es, at, Nigéria, se, gb, nl (code pays fourni par la source)

Active Ingredients in Digital Cognitive Interventions: Integrating Dismantling Designs with Mechanistic Neuroscience (Preprint)

Sarah Shizuko Morimoto, Cutter Augustus Lindbergh, Alexander C. Conley, Dusti R. Jones et autres

Relationship of cholinergic basal forebrain atrophy with the time course of Alzheimer's disease pathology and cognitive decline in adults with Down syndrome: a longitudinal cohort study

Jason K Russell, Zinayida Schlachetzki, Alexander C. Conley, Brian D. Boyd et autres

us (code pays fourni par la source)

Association of cholinergic integrity measured by [ 18 F]‐fluoroethoxybenzovesamicol with age and amyloid burden in adults with Down syndrome

Jason K Russell, Alexander C. Conley, Brian D. Boyd, John P. Begnoche et autres

us (code pays fourni par la source)

Computerized Memory Enhancement using NeuroFlex for Patients with Mild Cognitive Impairment: Results of a Pilot and Feasibility Study

Alexander C. Conley, S Shizuko Morimoto, Jennifer N. Vega, John P. Begnoche et autres

us (code pays fourni par la source)

Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M1 positive allosteric modulator VU0467319 for Alzheimer’s disease: a single ascending-dose study in healthy participants

Alexander C. Conley, Alexandra P. Key, Jennifer Urbano Blackford, Jason K Russell et autres

us (code pays fourni par la source)

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer’s disease: A Single Ascending-Dose Study in Healthy Participants

Alexander C. Conley, Alexandra P. Key, Jennifer Urbano Blackford, Jason K Russell et autres

us (code pays fourni par la source)

Brain cholinergic terminal density utilizing [18F]‐fluoroethoxybenzovesamicol PET in adults with Down's syndrome: Relationship to amyloid PET and cognitive performance

Jason K Russell, Alexander C. Conley, Brian D. Boyd, John P. Begnoche et autres

us (code pays fourni par la source)

Resistance and resilience to Alzheimer's disease in Down syndrome

Rory Boyle, Elouise A. Koops, Beau M. Ances, Elizabeth J. Andrews et autres

us, es, ar, ie, cn, br, gb, au, ch (code pays fourni par la source)

Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [18F]-fluoroethoxybenzovesamicol positron emission tomography imaging

Jason K Russell, Alexander C. Conley, Brian D. Boyd, John P. Begnoche et autres

us (code pays fourni par la source)

Relationship between electrophysiological performance during an incidental memory task and cholinergic integrity in a pilot study in adults with Down syndrome

Alexander C. Conley, Jason K Russell, John P. Begnoche, Brian D. Boyd et autres

us (code pays fourni par la source)

Investigating the association between cholinergic integrity and amyloid burden using cholinergic anatomy and [18F]‐FEOBV PET in individuals with Down Syndrome from the ABC‐DS and TRC‐DS cohorts

Jason K Russell, Alexander C. Conley, Brian D. Boyd, Rachel Schlossberg et autres

us (code pays fourni par la source)